UTHR acquires MIRO for $3.25/sh cash+CVR—a 213% premium to Friday’s close (excluding the CVR): https://www.globenewswire.com/news-release/2023/10/30/2768979/0/en/United-Therapeutics-to-Acquire-Miromatrix-Medical.html The nominal deal value is $91M.